3911 Sorrento Valley Road
San Diego, CA 92121
Marketing and Captisol Customer Service
Senior Vice President, Technical Operations
Dr. Antle joined Ligand in 2011 following Ligand's acquisition of CyDex Pharmaceuticals. He joined CyDex in 2005. Dr. Antle is currently responsible for quality assurance, internal drug product quality, operations, distribution and logistics for Captisol. From 1999 to 2005 Dr. Antle was Technical Operations Manager and Head of Process Development at EaglePicher Pharmaceuticals Services. Prior to 1999, Vince was the Group Leader for the Combinatorial Chemistry Department of MDS Panlabs in Bothell Washington. Dr. Antle has contributed to publications, presentation and patents and holds a Ph.D. from the University of Cincinnati in Medicinal Chemistry, and a B.A. in Chemistry from the University of Minnesota, Morris.
Vice President, New Product Development
Dr. Pipkin joined Ligand in 2011, following Ligand's acquisition of CyDex Pharmaceuticals. He joined CyDex in 2001. Dr. Pipkin's responsibilities include leading internal or assisting clients with development of new applications, intellectual property and products utilizing CAPTISOL, whether the application involves new molecular entities (NMEs), an Orphan designated drug, or reformulations of existing drugs for life cycle management via the 505(b)(2) regulatory pathway. Prior to joining the Company, he was Executive Director for CMC Services and Director of Formulation Development at Oread Laboratories from 1995 to 2001. From 1986 through 1995, he was a Research Fellow with Merck Research Laboratories in the INTERx Research Division and West Point PR&D facilities; his area of research interest was in the design and evaluation of controlled release devices for ophthalmic and oral delivery to enhance therapeutic efficacy and lower systemic burden. He was at The Squibb Institute for Medical Research from 1980 through 1985, where he directed the preformulation activities for new chemical entities. He has contributed to numerous presentations, publications and patents and holds a M.S. and Ph.D. from The University of Kansas in Pharmaceutical Chemistry, and B.A. in Mathematics and Chemistry from Kansas University.